Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: Spain Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20091
20101
20122
20141
20151
20161
20172
20182
20191
20202
20222
20231
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting5
Recruiting4
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
pharmaand GmbH3
AbbVie2
Amgen2
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
ImmunoGen, Inc.2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Advenchen Laboratories, LLC1
CanariaBio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms28
Ovarian Neoplasms23
Carcinoma, Ovarian Epithelial14
Peritoneal Neoplasms7
Neoplasms3
Recurrence2
Endometrial Neoplasms1
Neoplasm Metastasis1
Pathologic Complete Response1
Uterine Cervical Neoplasms1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.